Citadel Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Citadel Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-313,988	Closed	-$16.8M	–	8059
2016 Q1	$16.8M	Sell	313,988 -403,440	-56%	-$29.8M	0.02%	853
2015 Q4	$81M	Buy	717,428 +151,897	+27%	+$16.7M	0.09%	237
2015 Q3	$66.6M	Buy	565,531 +397,538	+237%	+$51.9M	0.06%	322
2015 Q2	$13M	Buy	167,993 +98,278	+141%	+$6.44M	0.01%	1290
2015 Q1	$4.03M	Buy	69,715 +62,212	+829%	+$2.64M	﹤0.01%	2259
2014 Q4	$242K	Sell	7,503 -321,474	-98%	-$9.65M	﹤0.01%	5743
2014 Q3	$8.05M	Buy	+328,977	New	+$6.68M	0.01%	1545
2014 Q2	–	Sell	-11,520	Closed	-$231K	–	8877
2014 Q1	$231K	Buy	+11,520	New	+$223K	﹤0.01%	5362

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Citadel Advisors's ANAC Position: Q2 2016 in Review

Citadel Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 313,988 shares — an estimated $16.8M sold.

Citadel Advisors first reported a position in ANAC in Q1 2014 and held it in 8 quarters. The position peaked at $81M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Citadel Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Citadel Advisors sold 313,988 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $16.8M.
Citadel Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 8 quarters.
Citadel Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $81M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Citadel Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.